TenNor Therapeutics (Suzhou) Limited (HKG:6872)
Hong Kong · Delayed Price · Currency is HKD 202.00
-1.60 (-0.79%)
Jun 1, 2026, 4:08 PM HKT
HKG:6872 Market Cap
HKG:6872 has a market cap or net worth of 10.45 billion as of June 1, 2026.
Market Cap
10.45B
Enterprise Value
10.28B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
202.00
Market Cap Chart
Since May 22, 2026, HKG:6872's market cap has decreased from 10.92B to 10.45B, a decrease of -4.27%. That is a compound annual growth rate of -89.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 10.54B | -3.05% |
| May 28, 2026 | 10.87B | -2.33% |
| May 27, 2026 | 11.13B | -8.74% |
| May 26, 2026 | 12.19B | 11.66% |
| May 22, 2026 | 10.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 14.44B |
| TransThera Sciences (Nanjing) | 14.29B |
| CStone Pharmaceuticals | 12.87B |
| Nanjing Leads Biolabs | 12.19B |
| CARsgen Therapeutics Holdings | 10.77B |
| Everest Medicines | 10.59B |
| HBM Holdings | 10.14B |
| Alphamab Oncology | 8.81B |